Concepedia
Statistics
Publications
5
Citations
237
H-Index
Active since
2013
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Novartis (United States)
Beatrice Bauer-Probst is an author at Novartis (Switzerland) specializing in molecular oncology, molecular biology, and medicine.
Publications per year
2013–2024
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
Martin Schröder, Martin Renatus, Xiaoyou Liang et al. · Nature Communications · 2024 · 88 citations · Full text
Life Sciences, Medicinal Chemistry, Molecular Biology +13
Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors
Simon Wöhrle, Andreas Weiss, Moriko Ito et al. · PLoS ONE · 2013 · 57 citations · Full text
Medicine, Molecular Biology, Oncology +17
A Novel Potent Oral Series of VEGFR2 Inhibitors Abrogate Tumor Growth by Inhibiting Angiogenesis
Guido Bold, Christian Schnell, Pascal Furet et al. · Journal of Medicinal Chemistry · 2015 · 46 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen
Lina Schukur, Tamara Zimmermann, Ole Niewoehner et al. · Scientific Reports · 2020 · 31 citations · Full text
Life Sciences, Genetics, Molecular Biology +13
Protein destabilization underlies pathogenic missense mutations in ARID1B
Fanny Mermet‐Meillon, Ş Mercan, Beatrice Bauer-Probst et al. · Nature Structural & Molecular Biology · 2024 · 15 citations · Full text
Life Sciences, Genetics, Molecular Genetics +13
1–5 of 5